What do AI Overviews actually pull from a dermatology clinic's medical pages?

Who is a dermatology clinic actually competing with in an AI Overview?

Not the clinic down the road. Dermatology's highest-volume searches are symptom searches. What does melanoma look like, is this mole changing, why is this rash spreading. Those are the queries a clinic's marketing tends to chase, and they are the queries where a private practice is up against the NHS, the British Association of Dermatologists and the large American health publishers.

Google treats them differently too. After the first wide rollout of AI Overviews, Elizabeth Reid, VP of Search, wrote in May 2024 that for topics like news and health strong guardrails were already in place, and that in the case of health Google had launched additional triggering refinements to enhance its quality protections. Health is not a normal category in this system.

So the honest read is that a clinic page explaining what a basal cell carcinoma looks like is entering a contest it has no structural advantage in. The page that describes the condition is a commodity. The page that describes what happens next at your clinic is not, and that distinction runs through the rest of this guide.

Can a skin clinic pay to appear inside the AI Overview?

No, and this is worth knowing before the next budget conversation. Google's advertising documentation states that it does not currently show ads in AI Overviews for sensitive verticals like adult, alcohol, gambling, finance, healthcare, politics, and more. Healthcare is named.

What you can still buy is the space around it. Google says ads are eligible to show above or below the AI Overview in all the markets where AI Overviews are available. So for a dermatology clinic the answer block itself is the one part of that result page that cannot be bought at any budget. It is earned or it is absent.

That changes how a clinic should read a proposal. Search ads and the AI Overview are two separate problems with two separate solutions, and an agency quoting one budget that promises both is describing something Google does not currently sell.

Will patient reviews get a dermatology page quoted?

Less than they will in most other local industries, and the reason is specific rather than general. In the same May 2024 update, Google said it had updated its systems to limit the use of user-generated content in responses that could offer misleading advice.

A plumber's reviews and a dermatologist's reviews are not treated as the same material once the query is clinical. Reviews still matter for the profile, for the map pack and for the patient reading them, and we would never tell a clinic to stop asking. But a review saying the mole turned out to be nothing is exactly the category of user-generated advice Google has said it constrains on health questions.

The practical consequence is that the review strategy and the AI visibility strategy are not the same project for a skin clinic, even though they are close to the same project for a trade business.

What can your clinic say that the NHS and Mayo Clinic cannot?

The pathway. A national health body can describe melanoma better than you can and will always outrank you on that. What it cannot describe is what happens to a patient who contacts your clinic on a Tuesday, and that is where the checkable, unique content lives.

There is a published framework to build it on. NICE's skin cancer quality standard QS130, last updated on 24 January 2024, sets a quality statement that people with suspected melanoma, squamous cell carcinoma or a rare skin cancer are referred for an assessment using a suspected cancer pathway to have a diagnosis confirmed or ruled out within 28 days of referral. NICE also notes that this may be a face-to-face appointment or a virtual referral for assessment of images of the skin lesion, and that referrals should include macroscopic and dermatoscopic images.

Every one of those is a fact your page can state about your service, and none of them reads the same on another clinic's site.

• Whether you take direct patient enquiries or require a GP referral, and what changes if the lesion is suspicious.
• Whether you accept virtual referrals with images, and the image standard you need.
• Who performs the dermoscopy, and who reads the histology.
• How long a biopsy result takes at your laboratory, stated as a number.
• What happens if the result is malignant, including which multidisciplinary team the patient moves to.
• What a private pathway costs, and where it joins or leaves the NHS one.

Why does a skin cancer page promising a two week wait date the whole site?

Because that standard no longer exists. On 17 August 2023 NHS England wrote to trusts confirming changes effective from 1 October 2023, and the letter is unambiguous: the changes include the removal of the two-week wait standard in favour of a focus on the Faster Diagnosis Standard, and the rationalisation of ten standards into three core measures.

The three that remain are the 28-day Faster Diagnosis Standard at 75 per cent, a 62-day referral to treatment standard at 85 per cent, and a 31-day decision to treat to treatment standard at 96 per cent. NHS England added that the Faster Diagnosis Standard would rise to 80 per cent in 2025/26, and named the tumour types expected to perform hardest: it said performance against breast and skin specifically would need to be above 90 per cent. Dermatology is one of the two specialties called out by name.

One precision worth keeping, because the opposite error is easy. The two-week wait standard was retired, not the measurement. NHS England said providers would still be able to track time to first seen, the current two-week wait, in local and national datasets. So the clock still exists internally. The promise on your website does not.

This matters beyond accuracy. A patient page quoting a standard withdrawn three years ago is the clearest possible signal that nobody has revisited the clinical content, and it sits on exactly the kind of query where Google says it applies its strongest protections.

Which dermatology images help, and which ones are a liability?

Google's guidance asks you to look for ways to support text with high-quality, relevant images and videos where it makes sense. Dermatology is the specialty where that advice should land hardest, because the images are the clinical content. NICE builds them into the referral itself, expecting macroscopic and dermatoscopic images to an agreed standard.

The split is between clinical images and marketing images. A dermatoscopic image illustrating what your referral requires, or a photograph of the equipment a patient will actually sit in front of, is supporting evidence. A before-and-after gallery is a different object under advertising law in most of the markets we work in, carrying conditions on matching, editing, warnings and patient age that no clinical image carries.

We have set out those conditions in full in whether a clinic can advertise Botox to the public, so we will not repeat them here. The point for this guide is narrower: the image that is most tempting for a cosmetic page is the most regulated, and the image that is most useful on a medical page is barely used at all.

Why is the cosmetic half of the clinic harder to get quoted?

Because almost everything that makes cosmetic copy persuasive makes it unusable. The claims are less settled than medical ones, the language regulators restrict is precisely the reassuring language that converts, and testimonials, which are the natural proof for an elective procedure, are prohibited outright in some of these markets.

That is not an argument for neglecting the cosmetic pages. It is an argument for keeping them apart from the medical ones, which is a structural decision we worked through in whether a dermatology clinic should separate its cosmetic and medical pages. A merged services page inherits the strictest rule set that applies to anything on it, and then carries that restriction onto the medical content that did not need it.

The parts of this that are not dermatology-specific are the same in every industry, and we set out the full list of what a practice does not need to buy in the dental version of this question. Short version: no special schema, no AI text files, no chunking, no rewriting for machines.

What does a quotable dermatology page look like?

How do you tell whether your skin clinic pages are being used?

Search Console has a generative AI performance report covering AI Overviews and AI Mode, which Google says rolled out to all websites worldwide as of 31 August 2026. It reports impressions. Clicks, position and query data are not part of it, and the data is drawn from the Web search type already in the Performance report.

For a dermatology clinic that limitation bites in a particular way. You will be able to see that a page appeared, but not whether it appeared against a symptom query you were never going to win or a pathway query you should own. Reading it by page rather than by volume is the only useful approach: if the impressions are landing on the condition explainers and not on the referral and pathway pages, the content is aimed at the wrong contest.

Google also says to be wary of third-party tools that promise ranking success or claim to use internal Google metrics, because no third-party tool has access to its internal ranking or AI systems. Aesthetic and dermatology marketing has more of those tools than most sectors. If a number appears in a proposal, ask where it came from before you ask what it means.